Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Liver Neoplasms × Phlebotomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Smoking 1 Primary Dysautonomias 1 Polycystic Ovary Syndrome 1 Metabolic Syndrome 1 Lung Neoplasms 1 Liver Neoplasms 1 Insulin Resistance 1 Hyperandrogenism 1 Carcinoma, Squamous Cell 1

Interventions

Radiofrequency Ablation 5 lenvatinib 4 Radiosurgery 4 Electroporation 4 Radiotherapy 3 Hepatectomy 3 sintilimab 2 perflutren 2 Proton Therapy 2 Patient Navigation 2 Nutritional Status 2 Magnetic Resonance Spectroscopy 2 Liver Transplantation 2 Injections 2 Exercise 2 Dextrins 2 Cryosurgery 2 Control Groups 2 Anesthesia, General 2 toripalimab 1 tislelizumab 1 seocalcitol 1 pembrolizumab 1 motexafin gadolinium 1 gadofosveset trisodium 1 gadobutrol 1 gadobenic acid 1 erythromycin propionate-N-acetylcysteinate 1 durvalumab 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548910 2021-03-18

PRICE

Ottawa Hospital Research Institute

Phase NA Completed

62 enrolled 13 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡